2nd International Workshop on Klinefelter Syndrome
March 10 - 12, 2016 - Münster, Germany
These lectures review the background of Klinefelter syndrome, with particular discussion around the rates of underdiagnosis. The second lecture discusses the excess morbidity and mortality in the disease, emphasising the importance of timely diagnosis.
Hypogonadism does not exist in isolation. In this presentation, Dr. Saad highlights that men with hypogonadism often present with multiple comorbidities, especially obesity, diabetes, cardiovascular disease and osteoporosis.
Following this, Dr. Saad addresses widespread – but unfounded - concerns with testosterone therapy; cardiovascular risk and prostate cancer, and presents research showing that testosterone therapy actually benefits these conditions.
The topic of testosterone and cardiovascular risk/disease is hotly debated. In this presentation Prof. Hackett addresses the issue whether testosterone is a friend or foe for cardiovascular risk by presenting studies on the topic.
New studies - that were published after a few flawed studies that raised unsubstantiated concerns – support decades of research showing that testosterone therapy actually reduces cardiovascular risk.
March 20 - 24, 2015 - 30th Annual EAU Congress, Madrid
After a basic intro on hypogonadism, this series of lectures presents the latest on the association of testosterone, obesity and diabetes and provocative new research on testosterone, prostate cancer and LUTS. It also addresses the controversial issue of testosterone therapy and “Hormonophobia”.
October 15, 2014 - Bayer Symposium at the 8th European Congress on Andrology, Barcelona, Spain
In this lecture Dr. Saad presents effects of long-term testosterone treatment in obese hypogonadal men with and without type 2 diabetes, and Dr. Maggi gives a perspective on testosterone and cardiovascular risk.
April 11-15, 2014 - 29th Annual EAU Congress, Stockholm
From Europe’s largest annual event, covering topics such as long-term treatment with testosterone undecanoate, Point-Counterpoint - TRT and prostate health, and importance of achieving threshold testosterone levels, as well as a discussion on how to deal with the flawed and misleading studies.
This ISMH (International Society of Men's Health) presentation covers the basics of testosterone deficiency and its treatment. The ISMH Men's Health Academy is a great resource for health care professionals working in the field of men’s health.